These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1971644)

  • 1. Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute.
    Pizzo PA
    J Hosp Infect; 1990 Apr; 15 Suppl A():41-8. PubMed ID: 1971644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combating infections in neutropenic patients.
    Pizzo PA
    Hosp Pract (Off Ed); 1989 Jul; 24(7):93-100, 103-4, 107-10. PubMed ID: 2501330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.
    Kinsey SE; Machin SJ; Goldstone AH
    J Hosp Infect; 1990 Apr; 15 Suppl A():49-53. PubMed ID: 1971645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the febrile neutropenic patient.
    Mandell LA
    Can Med Assoc J; 1983 Apr; 128(8):915-7. PubMed ID: 6831337
    [No Abstract]   [Full Text] [Related]  

  • 6. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
    Viscoli C; Bruzzi P; Glauser M
    Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
    Shenep JL
    NCI Monogr; 1990; (9):117-22. PubMed ID: 2342588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in the management of febrile neutropenic cancer patients.
    Rubin M; Hathorn JW; Pizzo PA
    Cancer Invest; 1988; 6(2):167-84. PubMed ID: 3132310
    [No Abstract]   [Full Text] [Related]  

  • 9. The febrile neutropenic patient: newer options for empirical therapy.
    Rubin M; Walsh T; Butler K; Lee J; Lecciones J; Weinberger M; Roilides E; Gress J; Marshall D; Pizzo PA
    Haematol Blood Transfus; 1990; 33():531-8. PubMed ID: 2157645
    [No Abstract]   [Full Text] [Related]  

  • 10. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.
    Pater JL; Weir L
    J Clin Oncol; 1986 Mar; 4(3):346-52. PubMed ID: 3512784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.
    Hathorn JW; Rubin M; Pizzo PA
    Antimicrob Agents Chemother; 1987 Jul; 31(7):971-7. PubMed ID: 3310871
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
    Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
    J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
    Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
    Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy.
    Wade JC
    Rev Infect Dis; 1989; 11 Suppl 7():S1572-81. PubMed ID: 2690295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview.
    Lieschke GJ; Bell D; Rawlinson W; Green MD; Sheridan W; Morstyn G; Stuart-Harris R; Kefford RF; Levi J; Sorrell T
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S37-42. PubMed ID: 2693108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical antimicrobial therapy in the neutropenic host.
    Young LS
    N Engl J Med; 1986 Aug; 315(9):580-1. PubMed ID: 3526156
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutropenia and fever.
    Hughes WT
    Pediatr Infect Dis; 1983; 2(3 Suppl):S14-7. PubMed ID: 6866796
    [No Abstract]   [Full Text] [Related]  

  • 20. Monotherapy with pefloxacin in neutropenic febrile patients.
    Daniels-Bosman MS; Beun GD; Debrus-Palmans LL; Blijham GH
    Chemioterapia; 1987 Jun; 6(2 Suppl):410. PubMed ID: 3509459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.